Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01945853

Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)

Imaging Myelin Injury in Amyotrophic Lateral Sclerosis (ALS)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is a pilot study to identify the degree of grey and white matter involvement in patients with Amyotrophic Lateral Sclerosis (ALS) utilizing non-invasive techniques. The imaging to be utilized will be the 7 Tesla (7T) magnetic resonance imaging (MRI) of the brain. These results will be correlated to the ALS Functional Rating Scale - Revised (ALSFRS-R) score to assess if any changes in MRI can be predictive in the disability of the ALS patients at baseline and at 6 month intervals. The participants will be asked to return every 6 months for a neurological examination, ALSFRS-R assessment, measurement of the vital capacity and MRI as outlined above to monitor progression of the disease.

Conditions

Interventions

TypeNameDescription
DEVICE7 Tesla MRI

Timeline

Start date
2013-07-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2013-09-19
Last updated
2015-09-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01945853. Inclusion in this directory is not an endorsement.